butabarbital decreases effects of sufentanil SL by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep an eye on Carefully. Coadministration of CYP3A4 inducers might decrease sufentanil concentrations and efficacy, potentially precipitating withdrawal syndrome in sufferers who've formulated Actual physical dependence to suf